S. Selek Et Al. , "CONTRIBUTION OF IN VIVO DOSE MEASUREMENT TO THE INTENSITY MODULATED RADIOTHERAPY TECHNIQUEIN THE TREATMENT OF NASOPHARYNGEAL CANCER," ICMP 2103 , vol.1, no.2, Brighton, United Kingdom, pp.568, 2013
Selek, S. Et Al. 2013. CONTRIBUTION OF IN VIVO DOSE MEASUREMENT TO THE INTENSITY MODULATED RADIOTHERAPY TECHNIQUEIN THE TREATMENT OF NASOPHARYNGEAL CANCER. ICMP 2103 , (Brighton, United Kingdom), 568.
Selek, S., TUNÇEL, N., CATAN, N. İ., GENÇ, M., & ÜNAL, N., (2013). CONTRIBUTION OF IN VIVO DOSE MEASUREMENT TO THE INTENSITY MODULATED RADIOTHERAPY TECHNIQUEIN THE TREATMENT OF NASOPHARYNGEAL CANCER . ICMP 2103 (pp.568). Brighton, United Kingdom
Selek, Sevda Et Al. "CONTRIBUTION OF IN VIVO DOSE MEASUREMENT TO THE INTENSITY MODULATED RADIOTHERAPY TECHNIQUEIN THE TREATMENT OF NASOPHARYNGEAL CANCER," ICMP 2103, Brighton, United Kingdom, 2013
Selek, Sevda Et Al. "CONTRIBUTION OF IN VIVO DOSE MEASUREMENT TO THE INTENSITY MODULATED RADIOTHERAPY TECHNIQUEIN THE TREATMENT OF NASOPHARYNGEAL CANCER." ICMP 2103 , Brighton, United Kingdom, pp.568, 2013
Selek, S. Et Al. (2013) . "CONTRIBUTION OF IN VIVO DOSE MEASUREMENT TO THE INTENSITY MODULATED RADIOTHERAPY TECHNIQUEIN THE TREATMENT OF NASOPHARYNGEAL CANCER." ICMP 2103 , Brighton, United Kingdom, p.568.
@conferencepaper{conferencepaper, author={Sevda Selek Et Al. }, title={CONTRIBUTION OF IN VIVO DOSE MEASUREMENT TO THE INTENSITY MODULATED RADIOTHERAPY TECHNIQUEIN THE TREATMENT OF NASOPHARYNGEAL CANCER}, congress name={ICMP 2103}, city={Brighton}, country={United Kingdom}, year={2013}, pages={568} }